Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

20.0%

5 terminated/withdrawn out of 25 trials

Success Rate

76.2%

-10.3% vs industry average

Late-Stage Pipeline

16%

4 trials in Phase 3/4

Results Transparency

13%

2 of 16 completed trials have results

Key Signals

1 recruiting2 with results

Enrollment Performance

Analytics

Phase 1

4(30.8%)

N/A

4(30.8%)

Phase 3

3(23.1%)

Phase 2

1(7.7%)

Phase 4

1(7.7%)

13Total

Phase 1(4)

N/A(4)

Phase 3(3)

Phase 2(1)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (25)

Showing 20 of 25 trials

NCT05267613Phase 3Active Not Recruiting

Endoscopic Evidence of Maintenance of Healing With Oral NEXIUM in Patients 1 to 11 Years Old With Erosive Esophagitis.

Role: collaborator

NCT07415876Recruiting

Evaluating Urinary CXCL10 for Enhanced Detection of Acute Rejection in Kidney Transplant Patients With Low DD-CFDNA

Role: collaborator

NCT04158804Not ApplicableCompleted

PROcalcitonin Impact on Antibiotic Reduction, adverSe Events and AVoidable healthcarE Costs (ProSAVE): A RCT

Role: collaborator

NCT03266302Not ApplicableCompleted

Hemoadsorption for Prevention of Vasodilatory Shock in Cardiac Surgery Patients With Infective Endocarditis

Role: collaborator

NCT01733134Phase 3Withdrawn

Acute Heart Failure Patients With High Copeptin Treated With Tolvaptan Targets Increased AVP Activation for Treatment (ACTIVATE)

Role: collaborator

NCT05591911Completed

Urine Gene Analysis for Pathogen Detection

Role: collaborator

NCT03831490Completed

Study for Improving Maternal, Pregnancy and Child Outcomes

Role: collaborator

NCT05727202Completed

Project STARFISH - PRJ0002679

Role: lead

NCT04037176Phase 4Completed

Behandling af Boern Med Foedevareallergi Med Omalizumab (Xolair)

Role: collaborator

NCT05800158Completed

Butterfly - Clinical Performance Study

Role: lead

NCT05662800Unknown

Development of Peanut, Sesame, and Tree Nut Allergy in Polish Children at High Risk of Food Allergy

Role: collaborator

NCT04732013Unknown

Noninvasive Chromosomal Screening for Embryo Selection Trial

Role: collaborator

NCT03067298Completed

Prediction of Preeclampsia and Other Pregnancy Complications Following Combined Iterative Screening

Role: collaborator

NCT00982111Phase 3Completed

First-line Treatment of Patients With Stage IV Nonsquamous Non-Small Cell Lung Cancer With Necitumumab (IMC-11F8) and Pemetrexed-Cisplatin

Role: collaborator

NCT02261610Not ApplicableTerminated

Pulmonary Embolism and PCT. PE-PCT Study

Role: collaborator

NCT02340936Phase 1Completed

Clinical Trial to Determinate Dose, Security and Efficacy or Lenalidomide and Rituximab (LR)-ESHAP in Patients With Diffuse Large B-cell Lymphoma

Role: collaborator

NCT03992794Completed

Assessment of Disease Severity, Progression and Treatment in Infected Patients Presenting to the Emergency Department

Role: collaborator

NCT02727413Completed

Inflammatory Mediator Profiles During Heart Valve Replacement Surgery

Role: collaborator

NCT01752569Phase 1Terminated

A Study of Selumetinib in Patients With Kaposi's Sarcoma

Role: collaborator

NCT03288610Completed

Prediction of Inflammatory Response and Hypotensive Syndrome After Cardiac Surgery by Preoperative Copeptin Level

Role: collaborator